Published in Br J Pharmacol on July 01, 1986
Multiple components of the A1 adenosine receptor-adenylate cyclase system are regulated in rat cerebral cortex by chronic caffeine ingestion. J Clin Invest (1988) 0.97
Locomotor activity in mice during chronic treatment with caffeine and withdrawal. Pharmacol Biochem Behav (1993) 0.93
Protein measurement with the Folin phenol reagent. J Biol Chem (1951) 1743.91
Ligand: a versatile computerized approach for characterization of ligand-binding systems. Anal Biochem (1980) 28.03
Numbers of receptor sites from Scatchard graphs: facts and fantasies. Science (1982) 3.79
Adenosine receptors: targets for future drugs. J Med Chem (1982) 3.44
Alkylxanthines: inhibition of adenosine-elicited accumulation of cyclic AMP in brain slices and of brain phosphodiesterase activity. Life Sci (1979) 2.94
The role of adenosine and its nucleotides in central synaptic transmission. Prog Neurobiol (1981) 2.03
Tolerance to the humoral and hemodynamic effects of caffeine in man. J Clin Invest (1981) 2.03
The effect of methylxanthines and local anesthetics on fragmented sarcoplasmic reticulum. J Pharmacol Exp Ther (1969) 1.91
Psychotropic effects of caffeine in man. IV. Quantitative and qualitative differences associated with habituation to coffee. Clin Pharmacol Ther (1969) 1.72
Noradrenaline inhibition of acetylcholine release from guinea-pig brain. Eur J Pharmacol (1978) 1.30
Adenosine actions and adenosine receptors after 1 week treatment with caffeine. Acta Physiol Scand (1982) 1.07
Chronic caffeine consumption increases the number of brain adenosine receptors. Life Sci (1983) 1.02
Effect of adenosine, adenosine triphosphate, adenosine deaminase, dipyridamole and aminophylline on acetylcholine release from electrically-stimulated brain slices. Neuropharmacology (1983) 0.93
Up-regulation of rat cortical adenosine receptors following chronic administration of theophylline. Eur J Pharmacol (1982) 0.89
Caffeine tolerance: behavioral, electrophysiological and neurochemical evidence. Life Sci (1985) 0.83
Biphasic effect of methylxanthines on acetylcholine release from electrically-stimulated brain slices. Br J Pharmacol (1984) 0.80
Characterization of adenosine receptors in brain using N6 cyclohexyl [3H]adenosine. Brain Res (1982) 0.79
Acetylcholine release from rat cortical slices during postnatal development and aging. Neurobiol Aging (1983) 0.78
Behavioral and physical development of rats chronically exposed to caffeinated fluids. Fundam Appl Toxicol (1984) 0.78
Disappearance of low affinity adenosine binding sites in aging rat cerebral cortex and hippocampus. Neurosci Lett (1984) 0.78
Giant synaptic potentials in immature rat CA3 hippocampal neurones. J Physiol (1989) 4.91
Adenosine in the central nervous system: release mechanisms and extracellular concentrations. J Neurochem (2001) 2.63
Electrophysiological, biochemical, neurohormonal and behavioural studies with WAY-100635, a potent, selective and silent 5-HT1A receptor antagonist. Behav Brain Res (1996) 1.74
GABA mediated excitation in immature rat CA3 hippocampal neurons. Int J Dev Neurosci (1990) 1.51
Effects of novelty and habituation on acetylcholine, GABA, and glutamate release from the frontal cortex and hippocampus of freely moving rats. Neuroscience (2001) 1.50
Adenosine decreases aspartate and glutamate release from rat hippocampal slices. Eur J Pharmacol (1984) 1.19
Extracellular adenosine concentrations during in vitro ischaemia in rat hippocampal slices. Br J Pharmacol (1999) 1.16
Investigations into the acetylcholine output from the cerebral cortex of the cat in the presence of hyoscine. Br J Pharmacol Chemother (1967) 1.15
Effect of psychoactive drugs on the output of acetylcholine from the cerebral cortex of the cat. Eur J Pharmacol (1968) 1.15
Proteomic identification of proteins specifically oxidized by intracerebral injection of amyloid beta-peptide (1-42) into rat brain: implications for Alzheimer's disease. Neuroscience (2005) 1.14
Aniracetam restores object recognition impaired by age, scopolamine, and nucleus basalis lesions. Pharmacol Biochem Behav (1996) 1.11
Inhibition of cortical acetylcholine release and cognitive performance by histamine H3 receptor activation in rats. Br J Pharmacol (1996) 1.06
Behavioral and ultrastructural changes induced by chronic neuroinflammation in young rats. Brain Res (2000) 1.04
Investigation on acetylcholine, aspartate, glutamate and GABA extracellular levels from ventral hippocampus during repeated exploratory activity in the rat. Neurochem Res (2003) 1.03
Effects of morphine on brain and spinal acetylcholine levels and nociceptive threshold in the frog. Brain Res (1974) 1.02
Interleukin-1beta activates forebrain glial cells and increases nitric oxide production and cortical glutamate and GABA release in vivo: implications for Alzheimer's disease. Neuroscience (1999) 1.01
Taurine distribution in cat brain. J Neurochem (1972) 1.00
Investigations into the adenosine outflow from hippocampal slices evoked by ischemia-like conditions. J Neurochem (1993) 0.99
Enhanced acetylcholine release in the hippocampus and cortex during acquisition of an operant behavior. Brain Res (1996) 0.99
Experimental brain inflammation and neurodegeneration as model of Alzheimer's disease: protective effects of selective COX-2 inhibitors. Int J Immunopathol Pharmacol (2003) 0.99
Phosphorylation of the presynaptic protein B-50 (GAP-43) is increased during electrically induced long-term potentiation. Neuron (1992) 0.98
The selective cyclooxygenase-2 inhibitor rofecoxib suppresses brain inflammation and protects cholinergic neurons from excitotoxic degeneration in vivo. Neuroscience (2003) 0.98
Selective muscarinic antagonists differentially affect in vivo acetylcholine release and memory performances of young and aged rats. Neuroscience (1997) 0.95
Extracellular levels of amino acids and choline in human high grade gliomas: an intraoperative microdialysis study. Neurochem Res (2004) 0.94
A2 adenosine receptors: their presence and neuromodulatory role in the central nervous system. Gen Pharmacol (1996) 0.94
Oxiracetam prevents electroshock-induced decrease in brain acetylcholine and amnesia. Eur J Pharmacol (1986) 0.94
Effect of adenosine, adenosine triphosphate, adenosine deaminase, dipyridamole and aminophylline on acetylcholine release from electrically-stimulated brain slices. Neuropharmacology (1983) 0.93
Changes in cortical acetylcholine output induced by modulation of the nucleus basalis. Brain Res Bull (1986) 0.93
Reversal by relaxin of altered ileal spontaneous contractions in dystrophic (mdx) mice through a nitric oxide-mediated mechanism. Am J Physiol Regul Integr Comp Physiol (2007) 0.93
A1 and A2 adenosine receptors modulate acetylcholine release from brain slices. Eur J Pharmacol (1984) 0.92
Temporal correlation between adenosine outflow and synaptic potential inhibition in rat hippocampal slices during ischemia-like conditions. Brain Res (1998) 0.92
Electrical stimulation of the stratum radiatum increases the release and neosynthesis of aspartate, glutamate, and gamma-aminobutyric acid in rat hippocampal slices. J Neurochem (1983) 0.92
Regional differences in the electrically stimulated release of endogenous and radioactive adenosine and purine derivatives from rat brain slices. Naunyn Schmiedebergs Arch Pharmacol (1990) 0.92
Effect of bicuculline and strychnine on the acetylcholine content of the amphibian spinal cord. Br J Pharmacol (1972) 0.92
Differential effects of amyloid peptides beta-(1-40) and beta-(25-35) injections into the rat nucleus basalis. Neuroscience (1995) 0.91
Upper aerodigestive tract foreign body injury prevention: an ENT evidence-based perspective. Acta Otorhinolaryngol Ital (2005) 0.91
Altered tachykinergic influence on gastric mechanical activity in mdx mice. Neurogastroenterol Motil (2006) 0.91
NO synthesis inhibition decreases cortical ACh release and impairs retention of a conditioned response. Brain Res (2001) 0.91
Decrease of brain acetylcholine release in aging freely-moving rats detected by microdialysis. Neurobiol Aging (1988) 0.90
Fidia and neuroscience. Nature (1993) 0.90
Adenosine and glutamate extracellular concentrations and mitogen-activated protein kinases in the striatum of Huntington transgenic mice. Selective antagonism of adenosine A2A receptors reduces transmitter outflow. Neurobiol Dis (2004) 0.90
Serotonin blocks the long-term potentiation induced by primed burst stimulation in the CA1 region of rat hippocampal slices. Neuroscience (1992) 0.90
Tacrine administration enhances extracellular acetylcholine in vivo and restores the cognitive impairment in aged rats. Pharmacol Res (1997) 0.89
Peripheral administration of novel anti-inflammatories can attenuate the effects of chronic inflammation within the CNS. Brain Res (1999) 0.89
Peripheral motor action of glucagon-like peptide-1 through enteric neuronal receptors. Neurogastroenterol Motil (2010) 0.89
Effect of A2A adenosine receptor stimulation and antagonism on synaptic depression induced by in vitro ischaemia in rat hippocampal slices. Br J Pharmacol (1999) 0.89
Effect of magnocellular forebrain nuclei lesions on acetylcholine output from the cerebral cortex, electrocorticogram and behaviour. Arch Ital Biol (1982) 0.89
The release of acetylcholine from the brain: an approach to the study of the central cholinergic mechanisms. Prog Neurobiol (1973) 0.88
Adenosine and memory storage: effect of A(1) and A(2) receptor antagonists. Psychopharmacology (Berl) (1999) 0.88
Administration of amyloid beta-peptides into the medial septum of rats decreases acetylcholine release from hippocampus in vivo. Brain Res (1994) 0.88
Muscarinic receptor modulation of acetylcholine release from rat cerebral cortex and hippocampus. Neurosci Lett (1995) 0.88
Brain inflammatory reaction in an animal model of neuronal degeneration and its modulation by an anti-inflammatory drug: implication in Alzheimer's disease. Eur J Neurosci (2000) 0.87
Pharmacological characterization of D-aminophosphonovaleric acid antagonism of amino acid and synaptically evoked excitations on frog motoneurones in vitro: an intracellular study. Br J Pharmacol (1985) 0.87
Alterations of neurokinin receptors and interstitial cells of Cajal during and after jejunal inflammation induced by Nippostrongylus brasiliensis in the rat. Neurogastroenterol Motil (2002) 0.87
Effect of thyrotropin releasing hormone (TRH) on acetylcholine release from different brain areas investigated by microdialysis. Br J Pharmacol (1991) 0.87
Effects of novelty, pain and stress on hippocampal extracellular acetylcholine levels in male rats. Brain Res (1997) 0.86
Investigations into the relationship between phospholipids and brain acetylcholine. Adv Exp Med Biol (1976) 0.86
Scopolamine induced changes of brain acetylcholine and EEG pattern in cats with complete pontine transection. Arch Ital Biol (1966) 0.86
NMDA receptor antagonists decrease GABA outflow from the septum and increase acetylcholine outflow from the hippocampus: a microdialysis study. J Neurosci (1994) 0.86
Psychological aspects of risk appraisal in asphyxiation accidents: a review of the factors influencing children's perception and behaviour. Acta Otorhinolaryngol Ital (2005) 0.86
Effect of the selective 5-HT1A receptor antagonist WAY 100635 on the inhibition of e.p.s.ps produced by 5-HT in the CA1 region of rat hippocampal slices. Br J Pharmacol (1998) 0.86
Beta(1-40) amyloid peptide injection into the nucleus basalis of rats induces microglia reaction and enhances cortical gamma-aminobutyric acid release in vivo. Brain Res (1999) 0.85
Acetylcholine input from the cerebral cortex, choline uptake and muscarinic receptors in morphine-dependent, freely-moving rats. Neuropharmacology (1980) 0.85
Neurotensin modulation of acetylcholine and GABA release from the rat hippocampus: an in vivo microdialysis study. Neurochem Int (1998) 0.85
Gastroschisis in the rat model is associated with a delayed maturation of intestinal pacemaker cells and smooth muscle cells. J Pediatr Surg (2004) 0.85
Effect of K+ depolarization, tetrodotoxin, and NMDA receptor inhibition on extracellular adenosine levels in rat striatum. Eur J Pharmacol (1993) 0.85
Effect of subchronic administration of metrifonate, rivastigmine and donepezil on brain acetylcholine in aged F344 rats. J Neural Transm (Vienna) (2002) 0.85
Interactions among adenosine deaminase, adenosine A(1) receptors and dopamine D(1) receptors in stably cotransfected fibroblast cells and neurons. Neuroscience (2002) 0.85
Stimulation by morphine of acetylcholine output from the cerebral cortex of septal rats. Brain Res (1975) 0.85
Regulation of extracellular adenosine levels in the striatum of aging rats. Brain Res (1995) 0.85
Selective adenosine A(2a) receptor agonists reduce the apoptosis in an experimental model of spinal cord trauma. J Biol Regul Homeost Agents (2010) 0.84
Effect of adenosine, adenosine derivatives, and caffeine on acetylcholine release from brain synaptosomes: interaction with muscarinic autoregulatory mechanisms. J Neurochem (1986) 0.84
Myogenic NOS and endogenous NO production are defective in colon from dystrophic (mdx) mice. Am J Physiol Gastrointest Liver Physiol (2001) 0.84
Effect of otilonium bromide and ibodutant on the internalization of the NK2 receptor in human colon. Neurogastroenterol Motil (2011) 0.84
Glutamatergic regulation of acetylcholine output in different brain regions: a microdialysis study in the rat. Neurochem Int (1994) 0.84
Long-term changes in the aggregation state and toxic effects of beta-amyloid injected into the rat brain. Neuroscience (1998) 0.83
Striatal A2A adenosine receptors differentially regulate spontaneous and K+-evoked glutamate release in vivo in young and aged rats. Neuroreport (1999) 0.83
In vivo regulation of extracellular adenosine levels in the cerebral cortex by NMDA and muscarinic receptors. Eur J Pharmacol (1994) 0.83
Rivastigmine antagonizes deficits in prepulse inhibition induced by selective immunolesioning of cholinergic neurons in nucleus basalis magnocellularis. Neuroscience (2002) 0.83
Effects of DAU 6215, a novel 5-hydroxytryptamine3 (5-HT3) antagonist on electrophysiological properties of the rat hippocampus. Br J Pharmacol (1994) 0.83
Interactions between oxiracetam, aniracetam and scopolamine on behavior and brain acetylcholine. Pharmacol Biochem Behav (1987) 0.83